Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Oct 2, 2020
Date Accepted: Jan 15, 2021
Date Submitted to PubMed: Jan 19, 2021
Predicting public take-up of digital contact tracing during the COVID-19 crisis: Results of a national survey in Singapore
ABSTRACT
Background:
In the global outbreak of coronavirus disease 2019 (COVID-19), new digital solutions have been developed for infection control. In particular, contact tracing mobile applications provide a means for governments to manage both health and economic concerns. However, public reception of these applications is paramount to success, and global take-up rates have been low.
Objective:
In this study, we sought to identify sociodemographic factors predicting voluntary downloads of a contact tracing mobile application.
Methods:
A sample of 505 adults from the general community completed an online survey. As the primary outcome measure, participants indicated whether they had downloaded a contact tracing application introduced at the national level (“TraceTogether”). As predictor variables, we assessed: (1) participant demographics; (2) behavioral changes on account of the pandemic; and (3) pandemic severity (the number of cases and lockdown status).
Results:
Within our dataset, the strongest predictor of digital contact tracing take-up was the extent to which individuals had already adjusted their lifestyles because of the pandemic (Z = 13.97, p < .001). Network analyses revealed that take-up was most related to: using hand sanitizers, avoiding public transport, and preferring outdoor over indoor venues during the pandemic. However, demographic and situational characteristics did not significantly predict application downloads.
Conclusions:
Efforts to introduce contact tracing applications could capitalize on pandemic-related behavioral adjustments that individuals have made. Given that critical mass is needed for contact tracing to be effective, we urge further research to understand how citizens respond to contact tracing applications. Clinical Trial: ClinicalTrials.gov NCT04468581
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.